At this year's Marijuana Business Daily Awards in Las Vegas, Cansativa ranks among the finalists in the "Regional Game Changers" category in Europe, the Middle East, Africa and Oceania. The award is given to companies in the growing cannabis market whose business model and practices are regarded as trend-setting. MJBiz Daily is the largest international news agency for the cannabis industry. The nomination is in recognition of Cansativa's contribution to the security of supply of medical cannabis in Germany. Cansativa has a successful year 2019 to look back on: The pharmaceutical company received the manufacturing and import license as well as the GMP certification in both production sites this year. In addition, it also expanded its own portfolio by founding the subsidiary Cansativa Medical Devices.
"We are very delighted with this recognition and consider the nomination an honor for our efforts to professionalize the German medical cannabis market and thus contribute to an improved care situation for patients," says Benedikt Sons, CEO and founder of Cansativa. “At the same time, we are excited to see that our partners from Little Green Pharma in Australia and Bedrocan in the Netherlands have also been nominated. Both companies are manufacturers of medical cannabis products.”
The award ceremony will take place on 12 December 2019 at the Cosmopolitan Hotel in Las Vegas.